Interaction between the non-alcoholic fatty liver disease fibrosis score and vitamin D deficiency on left ventricular hypertrophy and impaired diastolic function in patients with type 2 diabetes mellitus

The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients. A total of 595 T2DM patients were recruited a...

Full description

Saved in:
Bibliographic Details
Published inDiabetology and metabolic syndrome Vol. 17; no. 1; pp. 307 - 11
Main Authors Li, Yun-Ming, Huang, Jia-Yi, Guo, Ran, Li, Shi-Ming, Chen, Cong, Wu, Min, Wang, Run, Liu, Ming-Ya, Yiu, Kai-Hang
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 01.08.2025
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients. A total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels. Left ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e' was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e' compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e' (P for interaction = 0.001). NFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score.
AbstractList The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients.AIMSThe present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients.A total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels.METHODSA total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels.Left ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e' was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e' compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e' (P for interaction = 0.001).RESULTSLeft ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e' was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e' compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e' (P for interaction = 0.001).NFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score.CONCLUSIONSNFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score.
Aims The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients. Methods A total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels. Results Left ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e' was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e' compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e' (P for interaction = 0.001). Conclusions NFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score. Keywords: Non-alcoholic fatty liver disease fibrosis score, Vitamin D deficiency, Left ventricular hypertrophy, Left ventricular diastolic dysfunction, Type 2 diabetes mellitus
The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients. A total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels. Left ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e' was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e' compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e' (P for interaction = 0.001). NFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score.
Abstract Aims The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients. Methods A total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels. Results Left ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e′ was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e′ compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e′ (P for interaction = 0.001). Conclusions NFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score.
The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients. A total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels. Left ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e' was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e' compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e' (P for interaction = 0.001). NFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score.
AimsThe present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients.MethodsA total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels.ResultsLeft ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e′ was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e′ compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e′ (P for interaction = 0.001).ConclusionsNFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score.
ArticleNumber 307
Audience Academic
Author Wu, Min
Huang, Jia-Yi
Li, Shi-Ming
Wang, Run
Chen, Cong
Guo, Ran
Liu, Ming-Ya
Li, Yun-Ming
Yiu, Kai-Hang
Author_xml – sequence: 1
  givenname: Yun-Ming
  surname: Li
  fullname: Li, Yun-Ming
– sequence: 2
  givenname: Jia-Yi
  surname: Huang
  fullname: Huang, Jia-Yi
– sequence: 3
  givenname: Ran
  surname: Guo
  fullname: Guo, Ran
– sequence: 4
  givenname: Shi-Ming
  surname: Li
  fullname: Li, Shi-Ming
– sequence: 5
  givenname: Cong
  surname: Chen
  fullname: Chen, Cong
– sequence: 6
  givenname: Min
  surname: Wu
  fullname: Wu, Min
– sequence: 7
  givenname: Run
  surname: Wang
  fullname: Wang, Run
– sequence: 8
  givenname: Ming-Ya
  surname: Liu
  fullname: Liu, Ming-Ya
– sequence: 9
  givenname: Kai-Hang
  surname: Yiu
  fullname: Yiu, Kai-Hang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40751154$$D View this record in MEDLINE/PubMed
BookMark eNptks1u1DAUhSNURH_gBVggS0iITYodx0m8rMrfSJXYwNpy7OvGo8QebGeqeUZeCmdSSouQF7GuvnvOvfE5L06cd1AUrwm-JKRrPkRCMe9KXLESkw53JX1WnJGWdSXjvDl5dD8tzmPcYty0rK1fFKc1bhkhrD4rfm1cgiBVst6hHtIdgENpAJS9SjkqP_jRKmRkSgc02j0EpG0EGQEZ2wcfbURR-QBIOo32NsnJOvQRaTBWWXDqgLLwCCahPbgUrJpHGdBw2EFIwe-Gw7HRTjtpA-gsLmNaLWe3TpX1djJlrRTRnU0DSrkZVQuaB4aIJhhHm-b4snhu5Bjh1f33ovjx-dP366_lzbcvm-urm1LlvWlJjWx42zaMdLVuG6kV0ZUymhjeKeAVZxhLneuVUn2jqtYo1XKuOsUY74DSi2Kz6movt2IX7CTDQXhpxbHgw62QIVk1gshGFYemlprrGhvet7ShncE9gcqYXmet96vWLvifM8QkJhtVXkg68HMUtKKsrWpMFtu3_6BbPweXN12oFi9pwH-pW5n9rTM-5eddRMVVx3JO8t5Npi7_Q-WjYbIqx8zYXH_S8O5RwwByTEP047y8UHwKvrmfcu4n0A-_50_kMlCtgMrpiQHMA0KwWHIt1lyLnGtxzLWg9DfxHey9
Cites_doi 10.2337/diacare.27.8.1879
10.1007/s11883-017-0637-2
10.1177/1479164113491125
10.1007/s11739-022-02966-2
10.1038/nrendo.2017.151
10.1002/hep.24737
10.1016/j.jhep.2024.04.031
10.1371/journal.pone.0157517
10.2337/diacare.24.1.5
10.1016/j.jacc.2009.07.054
10.1080/08037051.2018.1527177
10.1038/ajg.2016.51
10.1002/hep.26390
10.1007/s00125-005-1896-y
10.1093/ehjopen/oead108
10.1016/j.jdiacomp.2014.01.003
10.1016/j.atherosclerosis.2015.05.002
10.1016/j.jhep.2019.06.021
10.3390/nu11040794
10.1016/j.jacc.2017.05.031
10.1016/j.echo.2016.01.011
10.4093/dmj.2019.0001
10.3389/fendo.2022.992666
10.1016/j.jhep.2017.11.023
10.1172/JCI0215219
10.1161/CIRCULATIONAHA.110.955542
10.1002/hep.21496
10.1038/bonekey.2013.214
10.1016/j.atherosclerosis.2020.03.010
10.1007/s11892-021-01383-7
10.1016/j.dsx.2018.03.011
10.1161/01.CIR.55.4.613
10.1016/j.jhep.2018.10.033
10.1093/eurheartj/ehab809
10.3389/fendo.2020.564738
10.1002/hep.28431
10.1111/jgh.15387
10.2147/DMSO.S299422
10.1016/j.echo.2014.10.003
10.1038/s41430-020-0558-y
10.1253/circj.CJ-12-0722
10.1111/joim.12007
10.2147/DMSO.S203700
10.1111/jdi.13430
10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
10.3390/nu13030830
10.1016/j.cgh.2018.12.031
10.1016/j.jhep.2016.05.013
10.1016/j.atherosclerosis.2018.03.027
10.1002/hep.26156
10.1371/journal.pone.0058808
ContentType Journal Article
Copyright 2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
NPM
3V.
7QP
7TS
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
7X8
DOA
DOI 10.1186/s13098-025-01808-3
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Physical Education Index
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Physical Education Index
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic




PubMed
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1758-5996
EndPage 11
ExternalDocumentID oai_doaj_org_article_69729e64ad9d40f9b73638f0b1e2ffbd
A850186516
40751154
10_1186_s13098_025_01808_3
Genre Journal Article
GeographicLocations Canada
China
Shenzhen China
GeographicLocations_xml – name: Canada
– name: Shenzhen China
– name: China
GrantInformation_xml – fundername: the Sanming Project of Medicine in Shenzhen, China
  grantid: No. SZSM201911020
– fundername: High Level-Hospital Program, Health Commission of Guangdong Province, China
  grantid: No. HKUSZH201901001
– fundername: HKU-SZH Fund for Shenzhen Key Medical Discipline
  grantid: No. SZXK2020081
GroupedDBID ---
0R~
53G
5VS
7X7
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
DIK
E3Z
EBD
EBLON
EBS
ESX
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IEA
IHR
IHW
ITC
KQ8
M~E
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TUS
U2A
UKHRP
NPM
3V.
7QP
7TS
7XB
8FK
AZQEC
DWQXO
K9.
M48
PKEHL
PQEST
PQUKI
7X8
PUEGO
ID FETCH-LOGICAL-c4073-3fa697765184d76adc1d2cfd1f98ce929500ad6ad2ccb6c27fcc799c8c5598e33
IEDL.DBID 7X7
ISSN 1758-5996
IngestDate Wed Aug 27 01:20:50 EDT 2025
Sat Aug 02 17:30:47 EDT 2025
Wed Aug 06 19:28:27 EDT 2025
Wed Aug 06 19:14:40 EDT 2025
Tue Aug 05 03:51:26 EDT 2025
Tue Aug 05 02:11:47 EDT 2025
Wed Aug 06 16:36:42 EDT 2025
Thu Aug 07 06:14:17 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Vitamin D deficiency
Type 2 diabetes mellitus
Left ventricular diastolic dysfunction
Non-alcoholic fatty liver disease fibrosis score
Left ventricular hypertrophy
Language English
License 2025. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4073-3fa697765184d76adc1d2cfd1f98ce929500ad6ad2ccb6c27fcc799c8c5598e33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/3237013090?pq-origsite=%requestingapplication%
PMID 40751154
PQID 3237013090
PQPubID 54993
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_69729e64ad9d40f9b73638f0b1e2ffbd
proquest_miscellaneous_3235724013
proquest_journals_3237013090
gale_infotracmisc_A850186516
gale_infotracacademiconefile_A850186516
gale_healthsolutions_A850186516
pubmed_primary_40751154
crossref_primary_10_1186_s13098_025_01808_3
PublicationCentury 2000
PublicationDate 2025-Aug-01
PublicationDateYYYYMMDD 2025-08-01
PublicationDate_xml – month: 08
  year: 2025
  text: 2025-Aug-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Diabetology and metabolic syndrome
PublicationTitleAlternate Diabetol Metab Syndr
PublicationYear 2025
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References G Targher (1808_CR8) 2016; 65
Y Chen (1808_CR29) 2015; 241
Y Chen (1808_CR21) 2014; 28
1808_CR36
CL Roth (1808_CR40) 2012; 55
GA Nichols (1808_CR1) 2004; 27
HS Chun (1808_CR31) 2021; 36
D Kim (1808_CR30) 2013; 57
YC Li (1808_CR45) 2002; 110
SF Nagueh (1808_CR28) 2016; 29
A Zhou (1808_CR35) 2022; 43
GE Chung (1808_CR14) 2018; 272
Y Zheng (1808_CR5) 2018; 14
R Hidayat (1808_CR15) 2010; 42
ZM Younossi (1808_CR6) 2016; 64
Y-H Lee (1808_CR13) 2018; 68
H Darraj (1808_CR16) 2019; 12
K Hirose (1808_CR53) 2023; 3
1808_CR26
KG Alberti (1808_CR22) 1998; 15
A Sonaglioni (1808_CR52) 2022; 17
C Caussy (1808_CR10) 2021; 21
ACT Ng (1808_CR4) 2010; 122
ZM Younossi (1808_CR7) 2019; 71
B Li (1808_CR39) 2013; 8
SM Barbalho (1808_CR47) 2018; 12
K Amrein (1808_CR25) 2020; 74
Y Xiao (1808_CR17) 2020; 11
Q Chen (1808_CR32) 2020; 299
H Lee (1808_CR12) 2020; 44
O Kuloğlu (1808_CR19) 2013; 10
L Xiu (1808_CR20) 2021; 14
K Chin (1808_CR37) 2017; 19
JE Nelson (1808_CR41) 2016; 111
RB Devereux (1808_CR27) 1977; 55
A Dawson (1808_CR2) 2005; 48
MT Long (1808_CR33) 2016; 11
ZM Younossi (1808_CR9) 2019; 70
D Gao (1808_CR38) 2005; 2013
RM Kwok (1808_CR42) 2013; 58
S Warita (1808_CR50) 2012; 76
R Bouillon (1808_CR43) 2014; 3
P Angulo (1808_CR24) 2007; 45
1808_CR49
1808_CR48
B Williams (1808_CR23) 2018; 27
N Fan (1808_CR34) 2021; 12
1808_CR46
1808_CR11
1808_CR3
1808_CR51
P Ameri (1808_CR18) 2013; 273
I Portales-Castillo (1808_CR44) 2022; 13
References_xml – volume: 27
  start-page: 1879
  year: 2004
  ident: 1808_CR1
  publication-title: Diab Care
  doi: 10.2337/diacare.27.8.1879
– volume: 19
  start-page: 5
  year: 2017
  ident: 1808_CR37
  publication-title: Curr Atheroscler Rep
  doi: 10.1007/s11883-017-0637-2
– volume: 10
  start-page: 546
  year: 2013
  ident: 1808_CR19
  publication-title: Diab Vasc Dis Res
  doi: 10.1177/1479164113491125
– volume: 17
  start-page: 1425
  issue: 5
  year: 2022
  ident: 1808_CR52
  publication-title: Intern Emerg Med
  doi: 10.1007/s11739-022-02966-2
– volume: 14
  start-page: 88
  year: 2018
  ident: 1808_CR5
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2017.151
– volume: 55
  start-page: 1103
  year: 2012
  ident: 1808_CR40
  publication-title: Hepatology
  doi: 10.1002/hep.24737
– ident: 1808_CR51
  doi: 10.1016/j.jhep.2024.04.031
– volume: 11
  start-page: e0157517
  year: 2016
  ident: 1808_CR33
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0157517
– ident: 1808_CR3
  doi: 10.2337/diacare.24.1.5
– volume: 42
  start-page: 123
  year: 2010
  ident: 1808_CR15
  publication-title: Acta Med Indones
– ident: 1808_CR49
  doi: 10.1016/j.jacc.2009.07.054
– volume: 27
  start-page: 314
  year: 2018
  ident: 1808_CR23
  publication-title: Blood Press
  doi: 10.1080/08037051.2018.1527177
– volume: 111
  start-page: 852
  year: 2016
  ident: 1808_CR41
  publication-title: Am J Gastroenterol
  doi: 10.1038/ajg.2016.51
– volume: 58
  start-page: 1166
  year: 2013
  ident: 1808_CR42
  publication-title: Hepatology
  doi: 10.1002/hep.26390
– volume: 48
  start-page: 1971
  year: 2005
  ident: 1808_CR2
  publication-title: Diabetologia
  doi: 10.1007/s00125-005-1896-y
– volume: 3
  start-page: oead108
  issue: 6
  year: 2023
  ident: 1808_CR53
  publication-title: Eur Heart J Open
  doi: 10.1093/ehjopen/oead108
– volume: 28
  start-page: 286
  year: 2014
  ident: 1808_CR21
  publication-title: J Diab Compl
  doi: 10.1016/j.jdiacomp.2014.01.003
– volume: 241
  start-page: 145
  year: 2015
  ident: 1808_CR29
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2015.05.002
– volume: 71
  start-page: 793
  year: 2019
  ident: 1808_CR7
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2019.06.021
– ident: 1808_CR46
  doi: 10.3390/nu11040794
– ident: 1808_CR36
  doi: 10.1016/j.jacc.2017.05.031
– volume: 29
  start-page: 277
  year: 2016
  ident: 1808_CR28
  publication-title: J Am Soc Echocardiogr
  doi: 10.1016/j.echo.2016.01.011
– volume: 44
  start-page: 267
  year: 2020
  ident: 1808_CR12
  publication-title: Diab Metab J
  doi: 10.4093/dmj.2019.0001
– volume: 13
  start-page: 992666
  year: 2022
  ident: 1808_CR44
  publication-title: Front Endocrinol
  doi: 10.3389/fendo.2022.992666
– volume: 68
  start-page: 764
  year: 2018
  ident: 1808_CR13
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2017.11.023
– volume: 110
  start-page: 229
  year: 2002
  ident: 1808_CR45
  publication-title: J Clin Investig
  doi: 10.1172/JCI0215219
– volume: 122
  start-page: 2538
  year: 2010
  ident: 1808_CR4
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.955542
– volume: 45
  start-page: 846
  year: 2007
  ident: 1808_CR24
  publication-title: Hepatology
  doi: 10.1002/hep.21496
– volume: 3
  start-page: 480
  year: 2014
  ident: 1808_CR43
  publication-title: Bonekey Rep
  doi: 10.1038/bonekey.2013.214
– volume: 299
  start-page: 45
  year: 2020
  ident: 1808_CR32
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2020.03.010
– volume: 21
  start-page: 15
  year: 2021
  ident: 1808_CR10
  publication-title: Curr Diab Rep
  doi: 10.1007/s11892-021-01383-7
– volume: 12
  start-page: 501
  year: 2018
  ident: 1808_CR47
  publication-title: Diab Metab Syndr
  doi: 10.1016/j.dsx.2018.03.011
– volume: 55
  start-page: 613
  year: 1977
  ident: 1808_CR27
  publication-title: Circulation
  doi: 10.1161/01.CIR.55.4.613
– volume: 70
  start-page: 531
  year: 2019
  ident: 1808_CR9
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2018.10.033
– volume: 43
  start-page: 1731
  year: 2022
  ident: 1808_CR35
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehab809
– volume: 11
  start-page: 564738
  year: 2020
  ident: 1808_CR17
  publication-title: Front Endocrinol
  doi: 10.3389/fendo.2020.564738
– volume: 2013
  start-page: 357
  issue: 37
  year: 2005
  ident: 1808_CR38
  publication-title: Int J Obes
– volume: 64
  start-page: 73
  year: 2016
  ident: 1808_CR6
  publication-title: Hepatology
  doi: 10.1002/hep.28431
– volume: 36
  start-page: 1703
  year: 2021
  ident: 1808_CR31
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/jgh.15387
– volume: 14
  start-page: 1823
  year: 2021
  ident: 1808_CR20
  publication-title: Diab Metab Syndr Obes Targets Therapy
  doi: 10.2147/DMSO.S299422
– ident: 1808_CR26
  doi: 10.1016/j.echo.2014.10.003
– volume: 74
  start-page: 1498
  year: 2020
  ident: 1808_CR25
  publication-title: Eur J Clin Nutr
  doi: 10.1038/s41430-020-0558-y
– volume: 76
  start-page: 2755
  year: 2012
  ident: 1808_CR50
  publication-title: Circ J
  doi: 10.1253/circj.CJ-12-0722
– volume: 273
  start-page: 253
  year: 2013
  ident: 1808_CR18
  publication-title: J Intern Med
  doi: 10.1111/joim.12007
– volume: 12
  start-page: 853
  year: 2019
  ident: 1808_CR16
  publication-title: Diab Metab Syndr Obes Targets Therapy
  doi: 10.2147/DMSO.S203700
– volume: 12
  start-page: 1035
  year: 2021
  ident: 1808_CR34
  publication-title: J Diabetes Investig
  doi: 10.1111/jdi.13430
– volume: 15
  start-page: 539
  year: 1998
  ident: 1808_CR22
  publication-title: Diab Med
  doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
– ident: 1808_CR48
  doi: 10.3390/nu13030830
– ident: 1808_CR11
  doi: 10.1016/j.cgh.2018.12.031
– volume: 65
  start-page: 589
  year: 2016
  ident: 1808_CR8
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2016.05.013
– volume: 272
  start-page: 137
  year: 2018
  ident: 1808_CR14
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2018.03.027
– volume: 57
  start-page: 1357
  year: 2013
  ident: 1808_CR30
  publication-title: Hepatology
  doi: 10.1002/hep.26156
– volume: 8
  start-page: e58808
  year: 2013
  ident: 1808_CR39
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0058808
SSID ssj0067574
Score 2.361411
Snippet The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the...
Aims The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on...
AimsThe present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on...
Abstract Aims The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their...
SourceID doaj
proquest
gale
pubmed
crossref
SourceType Open Website
Aggregation Database
Index Database
StartPage 307
SubjectTerms 25-Hydroxyvitamin D
Alcoholics
Alfacalcidol
Antihypertensives
Blood platelets
Blood pressure
Body mass index
Calcifediol
Canada
Cholesterol
Diabetes
Diabetes mellitus (non-insulin dependent)
Diet therapy
Diseases
Doppler effect
Echocardiography
Fatty liver
Fibrosis
Heart
Heart enlargement
Heart failure
High density lipoprotein
Hypertension
Hypertrophy
Left ventricular diastolic dysfunction
Left ventricular hypertrophy
Liver diseases
Non-alcoholic fatty liver disease fibrosis score
Regression analysis
Structure-function relationships
Type 2 diabetes
Type 2 diabetes mellitus
Ventricle
Vitamin D
Vitamin D deficiency
Vitamin deficiency
Womens health
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9JLafp0k7RTKPRQTGzJLx3TRwiF9NRAbkIeSXQh2Q1rbyG_MX8qM5K9dNtDL70ZeyxbmtFoZjTzSYj3VWGVrjySk0O-SeW7Ou91QLqyqnDobVlzvfP59-bsovp2WV_-dtQX54QleOA0cMeNJvPPN5V12lVF0H2rSGRC0ZdehtA71r605s3OVNLBZAW31Vwi0zXHA2lqLiWTnKjWcURwZxmKaP1_6-Q_LM244pw-EY8nUxFO0i_uiwd--VQ8PJ82w5-JuxjNS4UJMOVbAdlzQB59btPRtwuEYMfxFq44_wKm7RgI5CSvhsUAA6NYgl06-LUY7fViCV_AeUaV4JJMoIavfBiBkyJjpNCu4Sd5rutxvSL-xBe5zpL0pqPGLVmS8ZO0WMa_ovYm4NYBOOILHPEFCXPEF64ZD3TcDM_FxenXH5_P8ulshhzJBVS5CpY40zY1eYiubazD0kkMrgy6Q082V10U1tF9idg3KNuA2GqNHTIivFfqhdij0fCvBKAL5LNoh5UuqlB2NhANyr7sgyd1LDPxcWaVuUkQHCa6Ll1jEmMNMdZExhqViU_MzS0lw2fHGyRUZhIq8y-hysRblgWTalG3SsCcdIx_SJ1uMvEhUrAaGInVdqpmoC4xoNYO5eEOJU1f3H08y5uZ1MdglFQtbynrIhPvto_5TU6JW_rVJtLUrWT3OBMvk5xuO00sqhln6fX_GIwD8UjGmcNZj4dib1xv_BFZYmP_Jk66e8A2NK4
  priority: 102
  providerName: Directory of Open Access Journals
Title Interaction between the non-alcoholic fatty liver disease fibrosis score and vitamin D deficiency on left ventricular hypertrophy and impaired diastolic function in patients with type 2 diabetes mellitus
URI https://www.ncbi.nlm.nih.gov/pubmed/40751154
https://www.proquest.com/docview/3237013090
https://www.proquest.com/docview/3235724013
https://doaj.org/article/69729e64ad9d40f9b73638f0b1e2ffbd
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA_agvgifrtazxEEH2TpbrJfeZJWW4vQImLh3kI2H3rQ3tXdvUL_Rv8pZ7LZk1Pw5Th2Z3Obm2Qyv8nML4y9KTItZOEMghzEJoVryrSV3uA3LTJrnM5Lqnc-PatOzovP83IeA259TKucbGIw1HZlKEa-L7ioaZdNZu-vfqZ0ahTtrsYjNG6zXaIuo1FdzzeAC33hupgKZZpqv6fHm5QOcCXaqiYVW4tR4Oz_1zL_5W-Gdef4PrsXHUY4GDX8gN1yy4fszmncEn_EfoWY3lieADHrCtCrA8T1qR4PwF0Y8HoYbuCCsjAgbsqAR6i86hc99MRlCXpp4Xox6MvFEj6CdcQtQYWZgA1fOD8ApUaGeKHu4Afi127oVqil8CBVW6L1tNi4Rn8y_CQumeGtsL1I39oDxX2B4r7AYYr7wiWxgg7r_jE7Pz769uEkjSc0pAaBoEiF1xU6kFWJONHWlbYmt9x4m3vZGIeeV5ll2uJ1bkxbGV57Y2opTWOIF94J8YTt4L_hnjEw1iNykdYUMit83miPMoa3eesdGmWesHeTqtTVSMShAoBpKjUqVqFiVVCsEgk7JG1uJIlEO1xYdd9VnJMKX51LVxXaSltkXra1QGvkszZ33PvWJuwVjQU1VqRuTIE6aIgFETtdJextkCBjMKCqdaxpwC4RrdaW5N6WJE5is317Gm8qGpFe_RnyCXu9uU1PUmLc0q3WQaasOYHkhD0dx-mm06iiktiWnv-_8RfsLg9zgrIa99jO0K3dS_S0hnYWptOM7R4enX35OgvxCvz8NM9_A6v5Lvo
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIgEXxLuBQgcJxAFFTZynDwgVSrWl3Z5aaW_G8QNWapOyyYL6p_gj_ClmnGTRgsStt1Uy8TqZ8Xi-8TwYe5lGKhGp1QhyEJuktszCSjiNv1QSGW1VnFG-8_Qkn5yln2bZbIP9HHNhKKxy1IleUZtGk498N-FJQadsInp3-S2krlF0ujq20OjF4she_UDI1r493Ef-vuL84OPph0k4dBUINYKXJEycytHoyTPENqbIldGx4dqZ2IlSW7QWsihSBq9zratc88JpXQihS021zC05QFHl38CNNyKwV8xWAA9t7yIdE3PKfLel6ZYhNYylMlllmKxtfr5HwL87wV_2rd_nDu6yO4OBCnu9RN1jG7a-z25OhyP4B-yX9yH26RAwRHkBWpFQN3Wo-oa7cw1Odd0VnFPUBwyHQOAQmjftvIWWameCqg18n3fqYl7DPhhLtSwoERRw4HPrOqBQTO-fVAv4inh50S0alAr_IGV3orY2OLhC-9X_JW7RflY43lAutgXyMwP5mYHD6GeGC6pC2i3bh-zsWnj3iG3i17BbDLRxiJSE0amIUheXyiGN5lVcOYubAA_Ym5FV8rIv_CE9YCpz2TNWImOlZ6xMAvaeuLmipKLd_kKz-CIHHSBx6lzYPFVGmDRyoioS1H4uqmLLnatMwHZIFmSfAbtSPXKvpKqL-NJ5wF57ClI-HbJaDTkU-EpUxmuNcnuNEpWGXr89ypsclFYr_yyxgL1Y3aYnKRCvts3S02QFJ1AesMe9nK5eGlmUUXWnJ_8ffIfdmpxOj-Xx4cnRU3ab-_VBEZXbbLNbLO0ztPK66rlfWsA-X_da_g0CBmj5
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interaction+between+the+non-alcoholic+fatty+liver+disease+fibrosis+score+and+vitamin+D+deficiency+on+left+ventricular+hypertrophy+and+impaired+diastolic+function+in+patients+with+type+2+diabetes+mellitus&rft.jtitle=Diabetology+and+metabolic+syndrome&rft.au=Li%2C+Yun-Ming&rft.au=Huang%2C+Jia-Yi&rft.au=Guo%2C+Ran&rft.au=Li%2C+Shi-Ming&rft.date=2025-08-01&rft.pub=BioMed+Central+Ltd&rft.issn=1758-5996&rft.eissn=1758-5996&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs13098-025-01808-3&rft.externalDocID=A850186516
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-5996&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-5996&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-5996&client=summon